Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy

Completed

• Conditions: Hormone Replacement Therapy, Post-Menopausal; Menopause
• Interventions: Drug: Marketed low dose hormone replacement therapy

• Registration Number: NCT01487304
• Lead Sponsor: Novo Nordisk A/S

Brief Summary

This study is conducted in Europe. The aim of this study is to verify the therapeutic effects of low-dose hormone replacement therapy (HRT) in female patients over adequately long time period in normal clinical practice conditions in the Czech Republic.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-04
• Primary Completion: 2006-06
• Study Completion: 2006-06
• Study First Submitted: 2011-12-05
• Study First Submitted QC: 2011-12-06
• Study First Posted: 2011-12-07
• Status Verified: 2016-10
• Last Update Submitted: 2016-10-14
• Last Update Posted: 2016-10-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 3760

Inclusion Criteria

• Post-menopausal

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Low dose HRT	Marketed low dose hormone replacement therapy	-

Primary Outcome Measures

Name	Time	Method
Breast tenderness

Secondary Outcome Measures

Name	Time	Method
Patient treatment satisfaction after switch to low dose HRT

Trial Locations

Locations (1)

Novo Nordisk Investigational Site; 🇨🇿 Prague, Czech Republic